EXHIBIT 99.1

Lowell Farms Inc. Announces Unaudited First Quarter 2022 Financial and Operational Results

Following recent milestone, Lowell Farms enters the year as the largest combined seller of packaged flower and all-flower pre-rolls in California

SALINAS, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born innovator in cannabis cultivation and maker of the legendary brand Lowell Smokes, announces unaudited revenue and operating results for the first quarter and fiscal year (ended March 31, 2022). All figures stated are in US Dollars.

First Quarter Financial Highlights:

Revenue Summary ($’s in ‘000)


          Q/Q Q/Q
    Dec 31, 2021 March 31, 2022   % Change $ Change
  CPG Revenues $ 8,219 $ 9,077   10 % 858  
  Bulk Product $ 2,609 $ 2,259   -13 % (350 )
  LFS $ 3,153 $ 350   -89 % (2,803 )
  Out-of-State Licensing $ 1,092 $ 723   -34 % (369 )
  Net revenue $ 15,073 $ 12,409   -18 % (2,664 )

“For the second quarter in a row, Lowell Farms has taken the lead as California’s largest combined seller of packaged flower and all-flower pre-rolls in California per Headset,” says Co-Founder and Chief Executive Officer Mark Ainsworth. “You get there by selling a consistent, quality product that consumers have learned to trust and that is exactly what we sell.

“We also continue to make great strides with our out-of-state licensing partnerships, rising to become one of the top players in both of those markets for pre-rolls. That is a strong statement about the power of that brand.”

Subsequent events to the first quarter ended March 31, 2022:

Operational Highlights and Ongoing Initiatives:
The Company’s focus remains on key initiatives to drive sustainable profitable growth as well as working closely with governing bodies to ensure effective changes in the cannabis industry taxation system that would make higher profitability possible.

“To compete with the black market, we have to do it with price, quality, safety, and partnership with governing bodies that control our industry,” said Chairman of the Board George Allen. “We need three things: good quality cannabis, a brand that people trust, and automation. We are on the right path to having all three.”

Q1 Financial Results Earnings Conference Call Details:
The conference call with management at 5:30 p.m. EDT on Tuesday, May 10, can be accessed using the following dial-in information:

U.S. and Canadian Toll Free: 1-877-407-0789
International: 1-201-689-8562
Webcast: Lowell Farms Inc.
Conference ID: 13728978

Please dial-in at least 10 minutes before the call to register.

The conference call will be webcast live and archived on the investor relations section of the Lowell Farms website at https://ir.lowellfarms.com/.

ABOUT LOWELL FARMS INC.
Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF) (the “Company”) is a California-based cannabis company with advanced production capabilities supporting every step of the supply chain, including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. Lowell Farms grows artisan craft cannabis with a deep love and respect for the plant, and prides itself on using sustainable materials – from seed to sale – to produce an extensive portfolio of award-winning originals, including Lowell Herb Co, House Weed, MOON, and Kaizen, for licensed retailers statewide.

Lowell Farms Inc. Media Contact
pr@lowellfarms.com 

Lowell Farms Inc. Investor Relations Contact
Bill Mitoulas
416.479.9547
ir@lowellfarms.com 

Lowell Farms Inc. Company Contact
Mark Ainsworth
ir@lowellfarms.com 

Forward-Looking Information and Statements
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current conditions, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved.” The forward-looking information and forward-looking statements contained herein may include, but are not limited to, the anticipated growth of Lowell Farm Services and the ability of the Company to successfully achieve its business objectives and expectations for other economic, business, and/or competitive factors. There can be no assurance that such forward-looking information and statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such forward-looking information and statements. This forward-looking information and statements reflect the Company’s current beliefs and are based on information currently available to the Company and on assumptions the Company believes are reasonable.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; operating and development costs; competition; changes in legislation or regulations affecting the Company; the timing and availability of external financing on acceptable terms; the available funds of the Company and the anticipated use of such funds; favorable production levels and outputs; the stability of pricing of cannabis products; the level of demand for cannabis product; the availability of third-party service providers and other inputs for the Company’s operations; lack of qualified, skilled labor or loss of key individuals; and risks and delays resulting from the COVID-19 pandemic. A description of additional assumptions used to develop such forward-looking information and a description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company’s disclosure documents, such as the Company’s annual information form filed on the SEDAR website at www.sedar.com and the Company's Form 10 filed on the SEC website at www.sec.com. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement.

The forward-looking information contained in this news release represents the expectations of the Company as of the date of this news release and, accordingly, is subject to change after such date. However, the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Neither the Canadian Securities Exchange nor its Regulation Service Provider has reviewed, or accepts responsibility for the adequacy or accuracy of, the content of this news release.

Use of Non-GAAP Financial Information

EBITDA is net income (loss), excluding the effects of income taxes (recovery); net interest expense; depreciation and amortization; and adjusted EBITDA also includes noncash fair value adjustments on investments; unrealized foreign currency gains/losses; share-based compensation expense; and other transactional and special expenses, such as out-of-period insurance recoveries and acquisition costs and expenses related to the markup of acquired finished goods inventory, which are inconsistent in amount and frequency and are not what we consider as typical of our continuing operations. Management believes this measure provides useful information as it is a commonly used measure in the capital markets and as it is a close proxy for repeatable cash generated by operations. We use adjusted EBITDA internally to understand, manage, make operating decisions related to cash flow generated from operations and evaluate our business. In addition, we use adjusted EBITDA to help plan and forecast future periods.

This measure is not necessarily comparable to similarly titled measures used by other companies. A reconciliation of this measure to Net Loss is provided below.


Condensed Consolidated Balance Sheets
(unaudited)
(in thousands)

    March 31,     December 31,  
    2022     2021  
ASSETS            
Current assets:            
Cash and cash equivalents   $                   5,886     $               7,887  
Accounts Receivable - net of allowance for doubtful accounts of $827 and $1,139 at March 31, 2022 and December 31, 2021, respectively   5,644     8,222  
Inventory   15,807     13,343  
Prepaid expenses and other current assets   2,702     1,976  
Total current assets   30,039     31,428  
Property and equipment, net   63,833     64,779  
Other intangibles, net   40,674     40,756  
Other assets   346     416  
             
Total assets   $             134,892     $         137,379  
             
LIABILITIES AND STOCKHOLDERS’ EQUITY            
Current liabilities:            
Accounts payable   $                   2,317     $               3,102  
Accrued payroll and benefits   744     650  
Notes payable, current portion   258     221  
Lease obligation, current portion   2,503     2,444  
Other current liabilities   6,224     3,706  
Total current liabilities   12,046     10,123  
Notes payable   19     28  
Lease obligation   33,407     34,052  
Convertible debentures   14,196     14,012  
Mortgage obligation   8,813     8,857  
Total liabilities   68,481     67,072  
STOCKHOLDERS' EQUITY            
Share capital   189,529     189,368  
Accumulated deficit   (123,118 )   (119,061 )
Total stockholders' equity   66,411     70,307  
             
Total liabilities and stockholders' equity   $             134,892     $         137,379  
             


Condensed Consolidated Statements of Cash Flows
(unaudited)
(in thousands)

             
    Three Months Ended
 
    March 31,     March 31,  
    2022     2021  
CASH FLOW FROM OPERATING ACTIVITIES            
Net loss   $                 (4,057 )   $                 (6,719 )
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization                      1,511                            908  
Amortization of debt issuance costs                         226                            204  
Share-based compensation expense                         161                            287  
Provision for doubtful accounts                         243                            224  
Termination of branding rights agreement                            -                              152  
Unrealized gain on change in fair value of investments                           70                          (106 )
Changes in operating assets and liabilities:            
Accounts receivable                      2,335                       (2,471 )
Inventory                     (2,464 )                        (653 )
Prepaid expenses and other current assets                        (726 )                       1,058  
Other assets                            -                              (9 )
Accounts payable and accrued expenses                      1,827                       (2,146 )
Net cash used in operating activities   $                  (874 )   $                (9,271 )
CASH FLOW FROM INVESTING ACTIVITIES            
Proceeds from asset sales    $ -     $                   1,980  
Purchases of property and equipment                        (483 )                        (373 )
Acquisition of business assets, net                            -                       (4,569 )
Net cash used in investing activities   $                  (483 )   $                (2,962 )
CASH FLOW FROM FINANCING ACTIVITIES            
Principal payments on lease obligations   $                    (586 )   $                    (580 )
Payments on notes payable                          (58 )                          (31 )
Proceeds from exercise of warrants and options                            -                            665  
Net cash (used) provided by financing activities   $                  (644 )   $                       54  
             
Change in cash and cash equivalents    $                 (2,001 )   $               (12,179 )
Cash and cash equivalents—beginning of year                      7,887                       25,751  
Cash, cash equivalents —end of period   $                 5,886     $               13,572  
             
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION            
Cash paid during the period for interest    $                  1,018     $                      846  
Cash paid during the period for income taxes    $                     268     $                        91  
             
OTHER NONCASH INVESTING AND FINANCING ACTIVITIES            
Purchase of property and equipment not yet paid for   $                       79      $ -  
Issuance of subordinate voting shares in exchange for net assets acquired    $ -     $                 34,237  
Liabilities assumed and receivable forgiveness in exchange for net assets acquired  $ -     $                   2,910  
Debt and associated accrued interest converted to subordinate voting shares  $ -     $                      665  
             


Condensed Consolidated Statements of Income (Loss)
(unaudited)
(in thousands, except per share amounts)

    Three Months Ended
 
    March 31,     March 31,  
    2022     2021  
Net revenue   $          12,409     $          11,026  
Cost of goods sold   10,835     12,503  
             
Gross profit (loss)   1,574     (1,477 )
             
Operating expenses            
General and administrative   2,164     2,460  
Sales and marketing   1,761     1,441  
Depreciation and amortization   108     324  
Total operating expenses   4,033     4,225  
             
Loss  from operations   (2,459 )   (5,702 )
             
Other income/(expense)            
Other income (expense)   (143 )   (229 )
Unrealized change in fair value of investment   (70 )   106  
Interest expense   (1,310 )   (831 )
Total other income (expense)   (1,523 )   (954 )
             
Loss before provision for income taxes   (3,982 )   (6,656 )
Provision for income taxes   75     63  
Net loss   $         (4,057 )   $         (6,719 )
             
Net loss per share:             
Basic   $             (0.04 )   $             (0.13 )
Diluted    $             (0.04 )   $             (0.13 )
Weighted average shares outstanding:              
Basic   100,118     53,592  
Diluted    100,118     53,592  
             


The table below reconciles Net Loss to Adjusted EBITDA for the periods indicated.

             
    Three Months Ended
 
    March 31,     March 31,  
(in thousands)   2022     2021  
Net loss   $              (4,057 )   $                (6,719 )
Interest expense                     1,310                            831  
Provision for income taxes                          75                              63  
Depreciation and amortization in cost of goods sold                     1,260                            584  
Depreciation and amortization in operating expenses                        108                            324  
Depreciation and amortization in other income (expense)                        143                               -    
EBITDA(1)                    (1,161 )                      (4,917 )
Investment and currency (gains)/ losses                          70                           (106 )
Share-based compensation                        161                            287  
Net effect of cost of goods on mark-up of acquired finished goods inventory                           -                              167  
Transaction and other special charges                          30                               -    
Adjusted EBITDA(1)   $                 (900 )   $                (4,569 )
(1) Non-GAAP measure